Company: NKLR
Filing Date: 2025-09-16
Form Type: 424B3
Source: 0001213900-25-087981
Chunk: 15

Company: Terra Innovatum Global N.V.
Filing Date: 2025-09-16
Form: 424B3
Chunk 15
---
 directors and executive officers of Terra Innovatum, have interests that are different from (and which may conflict with) the interests of GSR III’s shareholders generally. These conflicts of interest include, among other things, the interests listed below: •the fact that the current executive officers will become executive officers of PubCo and will enter into employment agreements at Closing with one of the Terra Entities; •the fact that if the Business Combination fails, Terra Innovatum will lose an opportunity to become a publicly listed company, along with the associated benefits such as improved liquidity, brand visibility, and access to broader investor pools; •the fact that the Business Combination aligns with Terra Innovatum’s long -termvision for expansion, and failure to complete the Business Combination could significantly delay or impair its ability to commercialize the SOLO; •the fact that the executive officers are also significant shareholders of Terra Innovatum and therefore, stand to benefit from the increased valuation following consummation of the Business Combination; •The fact that the executive officers will still continue to control the company post -BusinessCombination which may allow them to make decisions that benefit their personal interests, which may not always align with those of unaffiliated shareholders; GSR III is providing the accompanying proxy statement/prospectus and accompanying proxy card to its shareholders in connection with the solicitation of proxies to be voted at the General Meeting and at any adjournments or postponements of the General Meeting. Information about the General Meeting, the Business Combination and other related business to be considered by the GSR III shareholders at the General Meeting is included in the accompanying proxy statement/prospectus. Whether or not you plan to attend the General Meeting, all GSR III shareholders are urged to read carefully and in their entirety the accompanying proxy statement / prospectus, including the Annexes thereto and the accompanying financial statements of Terra Innovatum, PubCo and GSR III. In particular, you are urged to read carefully the section entitled “ Risk Factors ” beginning on page 23 of the accompanying proxy statement / prospectus. After careful consideration, the GSR III Board has approved the Business Combination Agreement and the Business Combination, and recommends that GSR III shareholders vote “FOR” adoption of the Business Combination Agreement and approval of the Business Combination, the Merger and the Plan of Merger, and “FOR” all other proposals presented to the GSR III shareholders in the accompanying proxy statement / prospectus. When you consider the GSR III Board’s recommendation of these proposals, you should keep in mind that certain G